Skip to Main Content

Amphastar Pharmaceuticals, Inc.

AMPH Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
AMPH Income Statement
AMPH Balance Sheet
AMPH Cash Flow

Recent trades of AMPH by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
AMPH Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
AMPH Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
AMPH Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by AMPH's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Medication delivery systems and methods Mar. 26, 2024
  • Patent Title: Small angle x-ray scattering methods for characterizing the iron core of iron carbohydrate colloid drug products Aug. 15, 2023
  • Patent Title: Highly purified recombinant human insulin (rhi) api and methods of producing the same Dec. 13, 2022
  • Patent Title: High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same Sep. 20, 2022
  • Patent Title: High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same Sep. 10, 2019
  • Patent Title: High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same Jun. 18, 2019
  • Patent Title: Methods of resolving racemic mixture to obtain (−)-huperzine a May. 14, 2019
  • Patent Title: Micronized insulin and micronized insulin analogues prepared under acidic conditions, and methods of manufacturing the same under acidic conditions Apr. 16, 2019
  • Patent Title: Method of purifying idraparinux sodium Jan. 23, 2018
  • Patent Title: Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate Mar. 10, 2015
  • Patent Title: Stable epinephrine suspension formulation with high inhalation delivery efficiency Feb. 05, 2013
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of AMPH in WallStreetBets Daily Discussion

AMPH News

Recent insights relating to AMPH

CNBC Recommendations

Recent picks made for AMPH stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AMPH

AMPH Top Shareholders
Shareholder
Shares Held
AMPH Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

AMPH Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view AMPH Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top